Can this document be signed electronically?

Yes. Electronic signatures are valid under the ESIGN Act (15 U.S.C. ch.96) and UETA where adopted; ensure intent, consent, signer attribution, and reliable record retention to meet legal tests for enforceability.

Do I need an ESIGN consumer disclosure for patients?

Yes for consumer-facing health authorizations. Provide a clear disclosure of the right to paper, demonstrate the patient can access electronic records, and offer a mechanism to withdraw consent (15 U.S.C. §7001(c)).

Are HIPAA Business Associate Agreements required?

Yes when a vendor stores, transmits, or processes PHI. Execute a BAA that defines permitted uses, safeguards, breach notifications, and return or destruction of PHI on contract termination.

What if a signer makes an error after signing?

Do not alter the signed original. Prepare a dated amendment or addendum signed by required parties, keep originals intact, and document the reason for the correction in the audit trail.

When should I use higher-assurance authentication?

For sensitive enrollments or when required by protocol or regulator, use identity proofing (KBA), multi-factor authentication, or other high-assurance methods consistent with 21 CFR Part 11 controls.

How long must I keep consent records?

Retain consent and associated records according to applicable rules: HIPAA six years (45 CFR §164.530(j)), sponsor agreements, and any FDA recordkeeping obligations; state law may require longer retention.

Electronic Signature
Templates
Healthcare
Healthcare Study Document

Healthcare Study Document

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE STUDY PARTICIPATION CONSENT

Study Identification

Study Title:

Principal Investigator: Institution/Sponsor:

Participant Information

Patient Name

Date of Birth: Gender:

Address Phone Emergency Contact

Insurance & Billing

Insurance Provider

Policy Number: Group Number:

Subscriber Name

Medical History

Current Medications Known Allergies Prior Surgeries / Hospitalizations Chronic Conditions

Description of Study Procedures

Purpose and Procedures: The investigator will explain the scientific rationale and procedures to be performed. Procedures include:

Risks, Benefits, and Alternatives

Risks: I understand the reasonably foreseeable risks and discomforts associated with participation, which may include: physical side effects, emotional distress, allergic reaction, or unforeseen risks. I acknowledge that the investigator has explained these risks and answered my questions.

Potential Benefits: I understand that potential benefits may include clinical information useful to my care or advancement of medical knowledge. Benefits are not guaranteed.

Alternatives: I have been informed of reasonable alternatives to participation, including standard treatments and the option of receiving no study intervention.

Confidentiality, Data Use, and HIPAA Authorization

Confidentiality: Study records that identify me will be kept confidential to the extent permitted by law. Identifiable information may be used for study operations, monitoring, auditing, or regulatory compliance. De-identified data and biological samples may be used for future research without additional consent unless prohibited by law.

HIPAA Authorization: By signing below, I authorize the disclosure of my protected health information (PHI) as necessary for the conduct of the study, including access by the sponsor, regulatory agencies, and their representatives for monitoring and auditing purposes. I understand I may refuse to sign this authorization; refusal will not affect my ability to receive routine medical care.

Authorize HIPAA release for study purposes:

Voluntary Participation and Withdrawal

Voluntary Participation: I understand that participation is voluntary, that I may decline to participate, and that I may withdraw from the study at any time without penalty or loss of benefits to which I am otherwise entitled.

Effect of Withdrawal: If I withdraw, the investigator may retain and continue to use information and samples collected prior to withdrawal to preserve the integrity of the research unless I specifically request destruction of identifiable samples and records in writing.

Compensation and Costs

Compensation: I understand any compensation or reimbursement for participation, if offered, will be described here:

Costs: I understand which study-related treatments or tests, if any, will be billed to my insurance and which will be provided at no cost. Specific billing questions should be discussed with study staff.

Injury and Liability

If I suffer injury as a direct result of study procedures, I understand the treatment options available and any financial responsibility for such treatment. I understand that signing this form does not waive my legal rights.

Optional Permissions

Permit storage of biological samples for future research:

Permit audio/video recording for research/documentation:

Permit contact for future studies:

Contact Information for Questions or Concerns

Study Contact Name Study Contact Phone Alternate Contact (Ethics/Compliance)

Authorization Expiration

This authorization for use and disclosure of PHI and study materials expires on:

Certification and Consent

By signing below I certify that I have read (or had read to me) and understand the information on this form, that my questions have been answered, and that I freely consent to participate in this study. I understand I will receive a copy of this signed consent document.

Printed Name:

Signature:

Date:

If signing as parent/guardian, relationship to participant:

What the Healthcare Study Document Is and Why It Matters

A Healthcare Study Document records participant enrollment, consent, protocol adherence, data collection, and authorization for use of protected health information in a clinical or observational study. It combines participant identification, consent language, study procedures, data-sharing permissions, and signatures to document lawful participation. Properly completed, it supports regulatory compliance, ethical oversight, and auditability for institutional review boards and sponsors. This template focuses on the U.S. regulatory context, including ESIGN/UETA validity for electronic signatures and HIPAA requirements for handling health data and records retention.

Why a Complete Healthcare Study Document Matters

A complete Healthcare Study Document provides legally recognized evidence of informed consent, documents PHI authorizations under HIPAA, and creates an auditable trail for IRB and sponsor review. Accurate forms reduce rework, support monitoring, and help protect participant rights and institutional compliance.

Teams That Prepare and Use This Document

Primary users include research coordinators, principal investigators, IRB administrators, sponsor clinical operations, and regulatory compliance officers responsible for enrollment and documentation.

Research coordinators: administer consent, verify eligibility, and maintain enrollment records securely.
Investigators: confirm protocol adherence, document clinically relevant events, and sign investigator attestations.
IRB and regulatory staff: review forms for compliance, audit trails, and record retention.

Additional users include auditors, legal counsel, and data managers who rely on complete records during monitoring, audits, and regulatory submissions.

Core Components That Every Healthcare Study Document Should Include

This section lists the structural elements commonly required in clinical and observational study records to ensure clarity, regulatory acceptability, and consistent data capture across sites.

Study Identification

Include the full study title, sponsor protocol number, site identifier, and version or amendment date so reviewers can match the document to the active protocol and any specific consent version.

Participant Information

Record full legal name, date of birth, contact details, medical record number, and any guardian or legally authorized representative details to ensure correct identity matching and follow-up.

Informed Consent Elements

Provide clear statements of purpose, procedures, risks, benefits, voluntary participation, alternatives, and withdrawal process so participants can make an informed choice consistent with IRB expectations.

PHI Authorization

Specify the scope, purpose, recipients, and duration of authorized protected health information use and disclosures to align with HIPAA authorization requirements.

Procedures and Schedule

Describe required study activities, visit schedule, specimen handling, and any billing or payment arrangements to avoid procedural ambiguity during conduct and monitoring.

Signatures and Audit Trail

Include dated signature blocks for participant, investigator, and witness (if required), plus an audit trail capturing signer identity, timestamp, and signing method for compliance and inspection readiness.

Step-by-Step: Preparing and Executing the Document

Follow these sequential steps to prepare, verify, and execute the Healthcare Study Document for compliant participant enrollment.

01

Prepare Document: Assemble protocol sections, consent language, and study identifiers precisely.
02

Confirm Eligibility: Verify inclusion/exclusion criteria and match with participant records.
03

Obtain Consent: Present consent, answer questions, and record signed consent form.
04

Finalize Records: Store originals, produce copies, and capture audit trail details.

Recommended Online Workflow Settings for eSubmission

Typical online workflow settings for e-submission and audit-trail capture in clinical study contexts to ensure traceability and compliance.

Field	Configuration
Signer Authentication	Email link with optional SMS code for additional verification
Identity Proofing	KBA or ID verification for high-assurance signer identity
Form Fields	Magic detection, conditional logic, and required validation for completeness
Audit Trail	Capture IP address, timestamp, and action log for each signer

Technical Capabilities to Look For in an eSignature Platform

Use an eSignature platform that supports detailed audit trails, secure storage, and a Business Associate Agreement when handling protected health information.

File Types: PDF, DOCX, HTML support
Integrations: EHR, EDC, CRMs via API
Authentication: SSO, MFA, and access logging

Where to Send the Completed Healthcare Study Document

This outlines where to submit signed Healthcare Study Documents: sponsor eCRF, institutional files, IRB records, and regulatory submission packages for inspection and monitoring.

Sponsor submission: Upload a signed copy to the sponsor eCRF or CTMS per study instructions.
IRB record: Provide the final signed form to the IRB record repository for auditability.
Clinical chart: Attach consent to the participant medical record per HIPAA and local policy.
Regulatory submission: Include copies in inspection packages or as required by sponsor/FDA review.

Time-Critical Actions and Expected Deadlines

Key deadlines govern consent timing, adverse event reporting, and required submissions to IRB and sponsors during active study conduct.

Consent Timing:

Obtain informed consent before any study-specific procedures or data collection begins.

Serious Adverse Events:

Report SAEs to sponsor and IRB per protocol; follow applicable FDA reporting timelines.

Protocol Deviations:

Notify IRB and sponsor promptly according to the study's deviation reporting plan.

Data Lock:

Resolve outstanding consent and data queries before planned database lock milestones.

Final Reports:

Provide signed records during study closeout and as required by sponsor agreements.

Security and Compliance Baseline for Handling Study Records

In-transit encryption: TLS 1.2 / 1.3 with modern cipher suites

At-rest encryption: AES-256 encryption for stored documents

Certifications: ISO 27001, SOC 2 Type II, PCI DSS

HIPAA compliance: BAA available; protects PHI

21 CFR Part 11: Supports FDA e-signature controls and auditability

Accessibility: WCAG 2.0 Level AA conformance

Penalties and Risks of Incomplete or Incorrect Documents

HIPAA violations: Civil and criminal penalties (45 CFR §164)

Invalid consent: May render collected data unusable

IRB noncompliance: Study suspension or corrective action

Data breach: Notification obligations and fines

Incorrect signature: May require re-consent or audit remediation

Regulatory inspection: Sponsor or FDA sanctions possible

Common Mistakes to Avoid When Preparing the Document

Using nicknames or initials on signature fields can prevent identity verification and trigger requests for reidentification or additional documentation, delaying enrollment and regulatory reporting.
Failing to include specific data-sharing permissions or recipient lists in PHI authorizations can violate HIPAA and invalidate consent for planned analyses or cross-site transfers.
Uploading low-quality scans or unsigned images may break audit trails and complicate electronic verification during monitoring and inspections.
Neglecting ESIGN consumer disclosure for patient-facing records risks noncompliance with 15 U.S.C. §7001(c) and can undermine enforceability of electronic consent.

Practical Tips for Accurate and Efficient Completion

Follow these practical controls to reduce errors, speed enrollment, and strengthen compliance with IRB and regulatory expectations.

Verify identity before signing

Confirm government ID and match full legal name and date of birth to the form. Document the verification method in the study record to avoid later challenges during monitoring or audits.

Use validated electronic fields

Enable required and conditional fields to prevent missing data. Use date pickers, dropdowns, and validation rules to minimize free-text errors and maintain consistent data for analysis.

Keep a clear amendment process

When protocol or consent changes occur, issue a dated amendment or re-consent procedure. Ensure versions are tracked so every participant has the appropriate consent version on file.

Preserve original and audit trail

Retain signed originals and an immutable audit trail showing signer identity, timestamps, and method. Maintain copies for IRB, sponsor, and regulatory inspection per retention policy.

Real-World Examples of Electronic Consent in Healthcare Studies

Two concise examples show typical needs and outcomes when adopting electronic or hybrid consent workflows in clinical settings.

Fertility Centers of Illinois

A multi-site clinic needed secure remote consent for patients across locations.

Implemented HIPAA-compliant electronic consent with API integrations.
John Butler, Founder, said the vendor's security and API support helped streamline consent capture and integrate signed records with clinic systems for monitoring and patient care.

University Clinical Study

An academic research team required remote enrollment for a multi-site observational study.

Rolled out conditional online forms and identity verification.
The team reduced enrollment delays, preserved complete audit trails for monitoring visits, and centralized signed consents for sponsor reporting and IRB reviews.

Who Has Authority to Sign These Documents

Principal Investigator

The principal investigator signs to attest that the study was conducted according to protocol and that consent procedures were observed. The PI's signature documents oversight responsibilities, delegated authorities, and serves regulatory accountability roles during inspections.

Authorized Representative

A legally authorized representative or guardian may sign when the participant lacks capacity; document the representative's authority and relationship and include the legal basis for substitution in participant records.

Pricing and Vendor Comparison for eSignature Platforms (signNow First)

Compare starting prices, trial availability, and fundamental features relevant to Healthcare Study Document workflows; signNow appears first for clarity of comparison.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Available	Available	Available	Available
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No
Envelope Cap	No cap	100 envelopes/user/year	Varies by plan	Varies by plan	Varies by plan

Frequently Asked Questions About the Healthcare Study Document

Answers to common questions on electronic signatures, HIPAA obligations, witness requirements, and correcting signed records in the U.S. research context.

Need help? Contact support

Can this document be signed electronically?
Yes. Electronic signatures are valid under the ESIGN Act (15 U.S.C. ch.96) and UETA where adopted; ensure intent, consent, signer attribution, and reliable record retention to meet legal tests for enforceability.
Do I need an ESIGN consumer disclosure for patients?
Yes for consumer-facing health authorizations. Provide a clear disclosure of the right to paper, demonstrate the patient can access electronic records, and offer a mechanism to withdraw consent (15 U.S.C. §7001(c)).
Are HIPAA Business Associate Agreements required?
Yes when a vendor stores, transmits, or processes PHI. Execute a BAA that defines permitted uses, safeguards, breach notifications, and return or destruction of PHI on contract termination.
What if a signer makes an error after signing?
Do not alter the signed original. Prepare a dated amendment or addendum signed by required parties, keep originals intact, and document the reason for the correction in the audit trail.
When should I use higher-assurance authentication?
For sensitive enrollments or when required by protocol or regulator, use identity proofing (KBA), multi-factor authentication, or other high-assurance methods consistent with 21 CFR Part 11 controls.
How long must I keep consent records?
Retain consent and associated records according to applicable rules: HIPAA six years (45 CFR §164.530(j)), sponsor agreements, and any FDA recordkeeping obligations; state law may require longer retention.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now